Hypericum extract LI 160: Clinical Trials

8 trials of Hypericum extract LI 160, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 7, Terminated 1
Phase 31Completed 1

Follow Hypericum extract LI 160: new trials by email Literature Review of Hypericum extract LI 160 trials Research Report on Hypericum extract LI 160

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
Herbal medicine (St. John's wort and Kava) - Depressive Disorder, Major, Anxiety Disorders
Phase 2CompletedThe University of Queensland502007-03-012008-05-19
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
St. John's Wort - Breast Cancer, Hot Flashes
Phase 2TerminatedWake Forest University Health Sciences92006-03-162021-09-29
A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome
St. John's wort, Placebo - Irritable Bowel Syndrome
Phase 2CompletedMayo Clinic702006-02-012010-03-09
St. John's Wort for Tobacco Cessation
Placebo, St. John's Wort-900 mg/day, St. John's Wort-1800mg/day - Smoking, Nicotine Dependence
Phase 2CompletedMayo Clinic1182005-09-012011-04-19
Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
Hypericum perforatum, Placebo - Attention Deficit Hyperactivity Disorder
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)592005-02-012007-10-26
St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
Hypericum perforatum (St. John's wort) - Anxiety Disorders, Mental Health
Phase 2 / Phase 3CompletedNational Center for Complementary and Integrative Health (NCCIH)562002-08-012007-09-26
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
St. John's Wort - Obsessive Compulsive Disorder
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)602002-05-012006-08-04
St. John's Wort Versus Placebo in Social Phobia
St. John's Wort - Phobic Disorders
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)402001-12-012006-08-18

Conditions studied

Anxiety Disorders (4)  ·  Psychological Well-Being (3)  ·  Phobia, Social (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Breast Carcinoma In Situ (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Compulsive Personality Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Generalized Anxiety Disorder (1)  ·  Hot Flashes (1)  ·  Irritable Bowel Syndrome (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Phobic Disorders (1)  ·  Smoking (1)

Sponsors

National Center for Complementary and Integrative Health (NCCIH) (4)  ·  Mayo Clinic (2)  ·  The University of Queensland (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (7)  ·  Australia (1)

Top investigators

Kenneth Kobak, PhD (2)  ·  Amit Sood, M.D., MSc (1)  ·  Jerome Sarris, BHSc (1)  ·  Leslie Taylo, MD (1)  ·  Leslie Taylor, MD (1)  ·  Michelle Naughton, PhD (1)  ·  Wei Zhang, MD (1)  ·  Wendy Weber, ND, MPH (1)  ·  Yuri A. Saito Loftus, M.D. M.P.H. (1)

Results publications

PMID 18544723, PMID 20590478, PMID 37230961

NIH funding

U10CA081851 (1)